We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sharing Data From FDA Reviews Is Next ‘Frontier’ of Agency Transparency
Sharing Data From FDA Reviews Is Next ‘Frontier’ of Agency Transparency
May 18, 2012
Devicemakers and the rest of the scientific community can and should benefit from the careful disclosure of FDA review data that industry and the agency currently keep closely guarded, FDA Commissioner Margaret Hamburg says.